-
Teva Pharmaceutical: Joint Venture With Takeda Will Be 'Instantly Accretive' To 2016 EPS And Beyond
Monday, December 28, 2015 - 10:55am | 211Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) established a joint business venture with Japan-based Takeda Pharmaceutical Company at the end of November. The companies updated the investment community on Sunday and offered details of their strategic partnership. According to a joint...
-
Seattle Genetics and Millennium to Present Brentuximab Vedotin Clinical Data
Monday, November 8, 2010 - 11:46am | 91Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that brentuximab vedotin will be featured in two oral presentations at the 52nd American Society of Hematology Annual Meeting and Exposition being held December...